Última Hora: "Empresas espanholas burlaram Portugal no combate aos incêndios - Revista Sábado" Fri, 23 Jun 2017 17:10:30 GMT   "Euromilhões. Jackpot de 79 milhões de euros - Diário de Notícias - Lisboa" Fri, 23 Jun 2017 20:42:00 GMT    "Golpe com falso cupom de desconto do Uber faz milhares de vítimas - OlemeNews" Sun, 25 Jun 2017 02:13:04 GMT    "Negociações para venda da TVI à Altice aceleram. Governo está a par do negócio - Dinheiro Vivo" Sat, 24 Jun 2017 19:03:00 GMT    "Ritz-Carlton. Os novos cruzeiros de luxo estão aí - Dinheiro Vivo" Sat, 24 Jun 2017 19:11:13 GMT    "Trabalhadores irão à Justiça contra presidente da Eletrobras - EXAME.com" Sat, 24 Jun 2017 19:23:00 GMT    "EMEL vai fiscalizar estacionamento durante 24 horas a partir de 2018 - Correio da Manhã" Fri, 23 Jun 2017 14:28:40 GMT    "Défice público subiu para 2,1% no primeiro trimestre - Diário de Notícias - Lisboa" Fri, 23 Jun 2017 23:02:12 GMT    "Quina de São João tem 12 apostas ganhadoras: cada uma leva R$ 11,6 milhões - Globo.com" Sun, 25 Jun 2017 02:01:26 GMT    "Atropelamento mortal vitimou mulher em Lisboa - Diário de Notícias - Lisboa" Sun, 25 Jun 2017 03:16:10 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Procure análises técnicas no nosso fórum aqui: Análises Técnicas
Nota: Os dados após 2009-10-29 são ainda temporários e poderão por isso ter o valor de Abertura errado até nova actualização...
Mudar para Gráfico Estático de Sepracor Inc.

Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Board Change
London South East (registration) (blog)
He has also held senior management positions at Sepracor, Inc. (now Sunovion Pharmaceuticals, Inc.), Accenture plc and GlaxoWellcome plc (now GlaxoSmithKline plc). ?Trevor trained as a microbiologist at University of Reading, obtaining a PhD in ...


Flex Pharma (FLKS) Says Christoph Westphal to Transition From Role as CEO, Remain as Chair; William McVicar ...
StreetInsider.com
Flex Pharma, Inc. (NASDAQ: FLKS), a clinical-stage biotechnology company that is developing innovative and proprietary treatments for cramps and spasticity associated with severe neurological diseases including amyotrophic lateral sclerosis (ALS ...

e mais »

Desloratadine Market Analysis and In-Depth Analysis on Market Dynamics, Emerging Trends, Growth Factors and ...
MilTech
Desloratadine Market Key Players Analysis: Pfizer, Teva, Wante Pharmaceutical?, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...

e mais »

Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
Business Wire (press release)
?With their successful partnership from their time at Sepracor, Bill and our CMO, Dr. Tom Wessel, are a great team to rapidly advance our Phase 2 clinical trials in MS, ALS and Charcot-Marie-Tooth with FLX-787 which will be amongst the most advanced ...

e mais »

Frequency Therapeutics Announces its Board of Directors and the Appointment of Marc A. Cohen as Chairman
Business Wire (press release)
The Board Members include Tim Barberich, founder and former CEO and Chairman of Sepracor, Inc. (now known as Sunovion), Marc Kozin, Senior Advisor and former President of L.E.K. Consulting, Robert S. Langer, Sc.D., Frequency Co-founder and the ...

e mais »

Sunovion Pharmaceuticals Inc. Announces Company Name Change
Business Wire (press release)
BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the acquisition of Sepracor by ...

e mais »

Hants Journal

Charlottetown's BioVectra expanding, setting up in Windsor
Hants Journal
In June, BioVectra, which produces ingredients for the global pharmaceutical industry, purchased the former Sepracor Canada Limited building in Windsor's industrial area. The company will upgrade the 55,000 square foot manufacturing facility for their ...

e mais »

Rewire

Religious Imposition Proponents Find an Ally in the White House
Rewire
Stirrup worked as a senior legislative adviser at Venable LLP from 2003 to 2008. The firm's clients between those years included AstraZeneca Pharmaceuticals, Sepracor Inc, and the National Association of Spine Specialists. Another hire, Anna Pilato, is ...


Sunovion Celebrates Five-Year Anniversary Milestone
Business Wire (press release)
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) announced today that it is celebrating its five-year anniversary. Sunovion was established in October 2010 following the integration of Sepracor Inc. and Dainippon ...

e mais »

Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases ...
PR Newswire (press release)
Those defendants include Allergan, Inc., Amgen, Inc., Bradley Pharmaceuticals, Inc., Eisai, Inc., Mallincrodt, Inc., Novo Nordisk, Inc., Reliant Pharmaceuticals, Inc., Sepracor, Inc., and Upsher-Smith Laboratories, Inc. The settlement with Genzyme ...

e mais »

POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
Business Wire (press release)
Prior to joining Sepracor, Mr. Adams was President and Chief Executive Officer of Kos Pharmaceuticals, Inc. until its acquisition by Abbott Laboratories. Mr. Adams has also held general management and senior international and national marketing ...

e mais »

San Francisco Business Times (blog)

Can depression be treated like cancer? This startup thinks so
San Francisco Business Times (blog)
In addition to Corrigan, who was CEO of Zalicus Pharmaceuticals and R&D chief at Sepracor Inc, BlackThorn's team includes Chief Scientific Officer Bill Martin, formerly discovery and development chief at Theravance Biopharma in South San Francisco ...
BlackThorn Therapeutics Launches to Develop Novel, Targeted Treatments for Neurobehavioral DisordersBusiness Wire (press release)

todos os 7 artigos de notícias »

Boston Globe

Sunovion gets OK for its epilepsy drug
Boston Globe
Marlborough biotech Sunovion Pharmaceuticals Inc. is preparing to start selling a new antiseizure pill early next year, following Food and Drug Administration approval of the medication. FDA regulators signed off on Sunovion's first epilepsy drug ...

e mais »

Reuters

Dainippon to buy US drug firm Sepracor for $2.6 billion
Reuters
BOSTON/TOKYO Dainippon Sumitomo Pharma Co Ltd agreed on Thursday to buy U.S. drugmaker Sepracor Inc for $2.6 billion, giving the Japanese firm a big, local sales force in the world's largest drugs market. The deal is the latest in a string of overseas ...


Sunovion Pharmaceuticals Canada Inc. Announces Company Name Change
Canada NewsWire (press release)
Sepracor Pharmaceuticals, Inc. changes name, maintains commitment to developing scientifically-advanced central nervous system, cardiovascular disease and infectious disease therapies that improve patients' lives. MISSISSAUGA, ON, Aug. 17, 2011 ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc. 


Largura do Site:

 Imagem de Fundo:

Copyright@1998-2017 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters